Abstract
Immunosenescence is associated with the occurrence of lethal diseases, such as infection and malignancy. Since endocrinosenescence occurs simultaneously with immunosenescence, we determined whether or not lymphocytes and T cell subsets were altered in post-menopausal women. The ability of hormone replacement therapy (HRT) to reverse or modify the aberrations of the cell populations observed in elderly women was also examined. Thirty-nine untreated post-menopausal women and 39 women on HRT were studied. The proportions of lymphocytes and T cell subsets (helper, cytotoxic and immature T cells, and naive and memory/activated T cells) were determined by two color flow cytometry. Thirteen women were examined before and during HRT. At late post-menopause (≥30 years post-menopausal period), the proportion of peripheral blood lymphocytes showed a tendency to decline (p=0.06) compared with that at early (≤10 years) postmenopause. Significant (p<0.05) decrease in naive T cells and an increase in memory/activated T cells occurred at late post-menopause compared to those at early post-menopause. The percentage of lymphocytes in women on HRT was significantly (p<0.05) higher than that in untreated women at late post-menopausal stage. Furthermore, in a prospective study, HRT induced a significant (p<0.02) increase in the percentage of lymphocytes but showed no effect on the aberrations of naive and memory/activated T cells. HRT prevents the decline in the lymphocytes observed in post-menopausal women. However, HRT appears not to influence the observed alteration in T cell subsets.
Similar content being viewed by others
References
Pawelec G., Solana R. Immunosenescence. Immunol. Today 1997, 18: 514–516.
De Paoli P., Battistin P., Santini G.F. Age-related changes in human lymphocyte subset: progressive reduction of the CD4, CD45R (suppresser inducer) population. Clin. Immunol. Immunopathol. 1988, 48: 290–296.
Ernst D.N., Hobbs M.V., Torbett B.E., Glasebrook A.L., Rehse M.A., Bottomly K., Hayakawa K., Hardy R.R., Weigle W.O. Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice. J. Immunol. 1990, 145: 1295–1302.
Nagelkerken I., Hertogh-Huijbregts A., Dobber R., Drager A. Age-related changes in lymphokine production related to a decreased number of CD45RBhiCD4+ T cells. Eur. J. Immunol. 1991, 21: 273–281.
Utsuyama M., Hirokawa K., Kurashima C., Fukuyama M., Inamatsu T., Suzuki K., Hashimoto W., Sato K. Differential age-change in the number of CD4+ CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood. Mech. Ageing Dev. 1992, 63: 57–68.
Stulnig T., Maczek C., Bock G., Majdic O., Wick G. Reference intervals for human peripheral blood lymphocyte subpopulations from “healthy” young and aged subjects. Int. Arch. Allergy Immunol. 1995, 108: 205–210.
Cossarizza A., Ortolani C., Paganelli R., Barbieri D., Monti D., Sansoni P., Fagiolo U., Castellani G., Bersani F., Londei M., Franceschi C. CD45 isoforms expression on CD4+ and CD8+ T cells throughout life from newborns to centenarians: implications for T cell memory. Mech. Ageing Dev. 1996, 86: 173–195.
Miller R.A. Immune system. In: Masoro E. (Ed.), Handbook of physiology: aging. Oxford University Press, New York, 1995, pp.555–590.
Eidinger D., Garrett T.J. Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation. J. Exp. Med. 1972, 136: 1098–1116.
Inmad R.D. Immunologic sex differences and the female predominance in systemic lupus erythematosus. Arthritis Rheum. 1978, 21: 849–852.
Weinstein Y., Ran S., Segal S. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J. Immunol. 1984, 132: 656–661.
Mylvaganam R., Ahu Y.S., Harrington W.J., Kim C.I., Gratzner H.G. Differences in T cell subsets between men and women with idiopathic thrombocytopenic purpura. Blood 1985, 66: 967–972.
Amadori A., Zamarchi R., De Silvestro G., Forza G., Cavatton G., Danieli G.A., Clementi M., Chieco-Bianchi L. Genetic control of the CD4/CD8 T cell ratio in humans. Nat. Med. 1995, 1: 1279–1283.
Olsen N.J, Kovaks W.J. Gonadal steroids and immunity. Endocr. Rev. 1996, 17: 369–384.
Khorrmann O., Yeung M., Vu L., Yen S.S.C. Effects of [norleucine27] growth hormone-releasing hormone (GHRH) (1–29)-NH2 administration on the immune system of aging men and women. J. Clin. Endocrinol. Metab. 1997, 82: 3590–3596.
Hammond C.B. Menopause and hormone replacement therapy; an overview. Obstet. Gynecol. 1996, 87: 2S–15S.
Suenaga R., Evans M.J., Mitamura K., Rider V., Abdou N.I. Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells. J. Rheumatol. 1998, 25: 1305–1312.
Brunelli R., Frasca D., Peronne G., Pioli C., Fattorossi A., Zichella L., Doria G. Hormone replacement therapy affects various immune cell subsets and natural cytotoxicity. Gynecol. Obstet. Invest. 1996, 41: 128–131.
Ligthart G.J., Corberand J.X., Fournier C., Galanaud P., Hijmans W., Kennes B., Muller-Hermelink H.K., Steinmann G.G. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech. Ageing Dev. 1984, 28: 47–55.
Sparrow D., Silbert J.E., Rowe J.W. The influence of age on peripheral lymphocyte count in men: a cross-sectional and longitudinal study. J. Gerontol. 1980, 35: 163–166.
Ho P.C., Tang G.W., Fu K.H., Fan M.C., Lawton J.W. Immunologic studies in patients with premature ovarian failure. Obstet. Gynecol. 1988, 71: 622–626.
Ho P.C., Tang G.W., Lawton J.W. Lymphocyte subsets and serum immunoglobulins in patients with premature ovarian failure before and after oestrogen replacement. Hum. Reprod. 1993, 8: 714–716.
Kurabayashi T., Yasuda M., Fujimaki T., Yamamoto Y., Oda K., Tanaka K. Effect of hormone replacement therapy on spinal bone mineral density and T lymphocyte subsets in premature ovarian failure and Turner’s syndrome. Int. J. Gynaecol. Obstet. 1993, 42: 25–31.
Manyonda I.T., Pereira R.S., Makinde V., Brincat M., Varma R.T. Effect of 17β-oestradiol on lymphocyte subpopulations, delayed cutaneous hypersensitivity responses and mixed lymphocyte reactions in post-menopausal women. Maturitas 1992, 14: 201–210.
Blue M.L., Daley J.F., Levine H., Schlossman S.F. Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J. Immunol. 1985, 134: 2281–2286.
Furukawa S., Sasai K., Matsubara J., Yabuta K., Hiramatsu K., Yamamoto J., Shirai T., Okumura K. Increase in T cells expressing the γ/δ receptor and CD4+CD8+ double-positive T cells in primary immunodeficiency complicated by human T-cell lymphotropic virus type I infection. Blood 1992, 80: 3253–3255.
Araki H., Terao K., Murayama Y., Kam K.H., Yoshikawa Y. Peripheral blood CD4+CD8+ lymphocytes in cynomolgus monkeys are of resting memory T lineage. Int. Immunol. 1997, 9: 591–597.
Effros R.B. Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Dev. Comparative Immunol. 1997, 21: 471–478.
Sansoni P., Cossarizza A., Brianti V., Fagnoni F., Snelli G., Monti D., Marcato A., Passeri G., Ortolani C., Forti E., Fagiolo U., Passeri M., Franceschi C. Lymphocyte subsets and natural killer cell activity in healthy old peaple and centinarians. Blood 1993, 82: 2767–2773.
Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J.N., Seeger M., Relkin N.R., Liao F., Checler F., Buxbaum J.D., Chait B.T., Thinakaran G., Sisodia S.S., Wang R., Greengard P., Gandy S. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 1998, 4: 447–451.
Clark R.A., Bessinger R. Clinical manifestations and predictors of survival in older women infected with HIV. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1997, 15: 341–345.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kamada, M., Irahara, M., Maegawa, M. et al. Effect of hormone replacement therapy on post-menopausal changes of lymphocytes and T cell subsets. J Endocrinol Invest 23, 376–382 (2000). https://doi.org/10.1007/BF03343741
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343741